Is CAR T-Cell Therapy Safe and Effective?
Cancer ResearchClinical TrialsImmunotherapyPediatric Cancer
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Telling Patients About CAR T-Cell Therapy
ImmunotherapyLeukemiaLymphomaPersonalized Medicine
Nurse Navigator Claire White describes the way she tells her patients what CAR T-cell therapy is and how it works.
Immunotherapy plus Chemotherapy Extends Survival for Patients with Metastatic Triple-Negative Breast Cancer
Breast CancerImmunotherapyMetastatic Breast Cancer
Triple-negative breast cancer has few treatment options. Promising results from recent clinical trials of immunotherapy combined with chemotherapy in patients with metastatic disease may soon change the way this aggressive cancer is treated. Just after this article was written, the FDA approved this combination for patients with triple-negative breast cancer.
Immunotherapy vs Targeted Therapy
Dr Morganna Freeman explains the difference between immunotherapies and targeted therapies in plain language for patients to easily understand.
Understanding Immunotherapy
Dr Morganna Freeman breaks down her methods for explaining immunotherapy to her patients.
Is Immunotherapy Appropriate Here?
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.
The Evolving Field of Treatment Modalities
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
Changing the Conversation: Immunotherapy and Long-Term Survival
Dr Morganna Freeman discusses some of the ways immunotherapy has changed cancer care, including the expectation for long-term survival and how to treat patients in remission.
Choosing Immunotherapy
Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
Immune Checkpoint Inhibitors Offer New Hope for Patients with Lung Cancer
ImmunotherapyLung Cancer
Several immune checkpoint inhibitors are now approved for patients with non–small-cell lung cancer, giving hope to patients living with this disease.
Page 1 of 4
Results 1 - 10 of 35

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.